Obat supplies contractors and independent contractors with invoicing software. The tool is constantly changing depending on input from customers and partners.
Cachet is a financial services marketplace on a mission to create a better, healthier platform economy. It gives gig workers [in ride-hailing] a single insurance policy across platforms that’s fairly priced, personalised and easy to use. With services that help platform workers reduce their costs, improve their net earnings and feel empowered in their lifestyle, we make the platform economy better for everyone.
RollingFunds is the creator of a credit management platform that simplifies access to cash financing for small and medium-sized businesses. The company's platform uses machine learning-based instant scoring algorithms to automate the granting and management of loans for very small businesses as small and medium-sized businesses. Through its technology, RollingFunds injects financing into B2B relationships and simplifies their integration into the environment.
Cake App mission is to become the leading software technology provider that analyzes financial data to help people better understand, control and improve their finances, supported by a business model that shares our revenue with users.
IPaidThat automatically imports the invoices you receive, and compares them with your bank transactions, to make sure you do not forget anything.
Monisnap is a French-based fintech providing remittance services.
Zaion developed a voice customer relationship solution, a chatbot software that automates conversations and offers voice customer relationship processing using remote advisors. Zaion is a European expert in customer relationship solutions augmented by Artificial Intelligence.
ACASI is an accounting tool for freelancers and independent accountants. Acasi provides solutions for accounting apps, balance sheets, tax declarations, advice from a dedicated coach, and cash monitoring and management. Acasi handles businesses' accounting needs in the same way that a typical accountant would.
MoneyTrack is a global, decentralized blockchain platform for Directed Money.
Smile & Pay offers electronic payment terminals that enable small and medium merchants to accept payments from a large customer base with smartphones for no fixed fee. The company’s products include PocketSmile, a mobile-sized terminal that accepts all credit cards; and MaxiSmile, a terminal that features a printer and mobile GPRS facilities. With Smile & Pay’s payment solutions, individuals can also track their receipts in real time through their computers or phones.
Particeep is a fintech providing banks, insurers, asset managers and their distributors with no code turnkey distribution solutions for their financial products and services in less than a month and without IT development. Particeep also offers a Rest API consisting of micro-banking, insurance and investment services to automate data sharing with any information system and third-party application.
RollingFunds is the creator of a credit management platform that simplifies access to cash financing for small and medium-sized businesses. The company's platform uses machine learning-based instant scoring algorithms to automate the granting and management of loans for very small businesses as small and medium-sized businesses. Through its technology, RollingFunds injects financing into B2B relationships and simplifies their integration into the environment.
IPaidThat automatically imports the invoices you receive, and compares them with your bank transactions, to make sure you do not forget anything.
Smile & Pay offers electronic payment terminals that enable small and medium merchants to accept payments from a large customer base with smartphones for no fixed fee. The company’s products include PocketSmile, a mobile-sized terminal that accepts all credit cards; and MaxiSmile, a terminal that features a printer and mobile GPRS facilities. With Smile & Pay’s payment solutions, individuals can also track their receipts in real time through their computers or phones.
MoneyTrack is a global, decentralized blockchain platform for Directed Money.
Géocorail développe et commercialise un produit innovant faisant travailler la mer à la protection du littoral : le Géocorail®. Ce procédé électrochimique breveté innovant consiste à créer une roche artificielle permettant de protéger les ouvrages marins et de lutter contre l’érosion du littoral.
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumors and varicose veins. Their companyTheraclion a French company created in 2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures, and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limbs.
Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.
Actility is an industry leader in Low Power Wide Area Networks (LPWAN). ThingPark by Actility offers a carrier-grade IoT platform, with a growing ecosystem of partners; low-power, long-range wireless networks for sensors and devices; an operating system and middleware that enables web applications to connect seamlessly with data from different sensors; and a B2B e-commerce market featuring tested and approved IoT device, connectivity, and application partners. Actility is a founding member of the LoRa Alliance™.
Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and public health needs. The company uses a proprietary technology for non-invasive intranasal delivery, and has shown proof of principle in animals and in initial human clinical studies. Vaxin Inc., formerly known as Vaxin Pharmaceuticals and ImmuneFocus Corporation, was founded in 1997 by Emerging Technology Partners. Early experiments revealed that DNA incorporated into an adenovirus can elicit an immune response when placed on the surface of the skin, and subsequently research was expanded to include applications on the skin in the nose as well as experimentation with other vectors.
SP3H's values are in tune with the environmental and energetic stakes of the 21st century. For this reason, their company innovates in ground-breaking technology, which aims to reduce carbon dioxide levels and fuel consumption.
Using 100% HTML5 technology, CoolGames has published hundreds of top-quality casual games including high-profile IPs such as Angry Birds, Tetris®, Snake, and Battleship since 2009. Click-and-play from the cloud with no downloads required, you can enjoy our everyday growing game portfolio anytime and anywhere!
Momac simplifies customer engagement for leading communication service providers. By bridging the technology gap between internal data systems, service offerings, content and on-device user interfaces, Momac allows CSPs to reduce costs, increase revenue and rapidly bring solutions to market. The mvolve platform drives mobile internet and app solutions for leading CSOs and operator groups around the world, including Orange Group, Vodafone, Telefonica, Three, KPN, T-Mobile, and more. Operating in 27 countries, Momac has offices in the US, UK, the Netherlands and France.
SP3H's values are in tune with the environmental and energetic stakes of the 21st century. For this reason, their company innovates in ground-breaking technology, which aims to reduce carbon dioxide levels and fuel consumption.
Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Using 100% HTML5 technology, CoolGames has published hundreds of top-quality casual games including high-profile IPs such as Angry Birds, Tetris®, Snake, and Battleship since 2009. Click-and-play from the cloud with no downloads required, you can enjoy our everyday growing game portfolio anytime and anywhere!
Biokinesis
Funding Round in 2011
Biokinesis is a biotechnology company developing new treatments for cancer by targeting a specific kinesin found in several cancers.
Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.
Utel is the creator of AlloKang, a sharing economy marketplace that democratizes access to advice from professional experts across Europe.
Actility is an industry leader in Low Power Wide Area Networks (LPWAN). ThingPark by Actility offers a carrier-grade IoT platform, with a growing ecosystem of partners; low-power, long-range wireless networks for sensors and devices; an operating system and middleware that enables web applications to connect seamlessly with data from different sensors; and a B2B e-commerce market featuring tested and approved IoT device, connectivity, and application partners. Actility is a founding member of the LoRa Alliance™.
Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Immune Targeting Systems (ITS) Limited is developing synthetic vaccines for mutating viruses. The Company's enabling T-cell vaccine platform enables it to target highly conserved parts of the virus ("antigens") and direct an T-cell immune response to those cells in the body infected with one of these difficult viruses. The fluoropeptide vaccine technology then delivers these antigens into the body and promotes robust T-cell immunity without requiring potentially toxic adjuvants which are normally used with vaccines to boost the responses achieved. The company was founded in late 2003 and is located at the London BioScience Innovation Centre, based in London. In June 2007 the company raised its first major venture capital funding from a syndicate of investors including the Novartis Venture Fund, HealthCap, Truffle Capital & the London Technology Fund. Alongside this investment, the London Development Agency has awarded ITS an Exceptional Development Grant.
Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurateâ„¢Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.
Eco-Carbone
Funding Round in 2008
Eco-Carbone provides consulting and project development services in the area of climate change mitigation.
CARMAT is a medtech company that develops and manufactures bioprosthetic artificial hearts for the healthcare industry. The company is offering biocompatible, auto-regulated total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart. It is designed for patients suffering from chronic terminal heart failure reaching class IV on the New York Heart Association classification; or acute terminal heart failure following a massive myocardial infarction. CARMAT’s aim is to offer a reliable new treatment and innovative therapeutic solution to heart failure patients, who are not eligible for a transplant and who have exhausted every drug-related possibility. It was launched in 2008 and is based in Vélizy-villacoublay.
Private Equity Round in 2007
OSEAD Maroc Mining operates as a metal and mining platform. OSEAD is a holding company specialising in the prospecting, exploration and mining of mineral deposits. OSEAD’s main asset is Compagnie Minière de Touissit the second largest private mining operator in Morocco, which mines primarily lead and silver with some zinc.
As of November 9, 2005, PeopleCube (UK) was acquired by PeopleCube, Inc. (formerly known as Meeting Maker, Inc.). PeopleCube provides intelligent on-demand workplace management solutions that help customers cut real estate, meeting services, travel, and energy costs based on actual workspace usage. Through its corporate headquarters in Framingham, Massachusetts, and offices throughout the world, PeopleCube supports 7,500 customers in small, medium, and large enterprises. PeopleCube helps businesses cut real estate, meeting services, travel and energy costs based on actual workspace usage. The UK predecessor, formerly known as The Internet Applications Group (UK), Ltd., was founded in 1995 and is based in Twickenham, the United Kingdom with an additional office in the Netherlands.
Immune Targeting Systems (ITS) Limited is developing synthetic vaccines for mutating viruses. The Company's enabling T-cell vaccine platform enables it to target highly conserved parts of the virus ("antigens") and direct an T-cell immune response to those cells in the body infected with one of these difficult viruses. The fluoropeptide vaccine technology then delivers these antigens into the body and promotes robust T-cell immunity without requiring potentially toxic adjuvants which are normally used with vaccines to boost the responses achieved. The company was founded in late 2003 and is located at the London BioScience Innovation Centre, based in London. In June 2007 the company raised its first major venture capital funding from a syndicate of investors including the Novartis Venture Fund, HealthCap, Truffle Capital & the London Technology Fund. Alongside this investment, the London Development Agency has awarded ITS an Exceptional Development Grant.
Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.
RF-iT Solutions GmbH provides radio frequency identification (RFID) software solutions and services. It develops and markets You-R® OPEN, an auto-ID software and RFID operating environment, which serves as a platform for system integrators, software manufacturers, and operators, as well as supports RFID infrastructure ranging from smart labels to readers, barcode scanners, label printers, and I/O devices. The company also provides RFID middleware; You-R Smart Fashion, a textile and apparel supply chain solution; You-R® DOCUTRACER, a Web-based application that stores data in a SQL-database for patent lawyers and hospitals; You-R® PHARMA, a solution for local packaging lines to capture item serial numbers, as well as the hierarchy of case/pallet serial numbers in pharmaceutical companies; You-R® RETAIL, an inventory solution for retailers; You-R® SECURE, a solution for manufacturer brand protection; and You-R® VIRTUAL TUNNEL, a solution the enables the allocation of single units to their packing units. In addition, it offers business case analysis, feasibility studies, testing, and technology consulting services. The company serves fashion, automotive, industrial manufacturing, pharmaceutical, retail, consumer packaged goods, logistics, asset management, and healthcare industries. RF-iT Solutions GmbH was founded in 2005 and is based in Graz, Austria. It has locations in Germany, France, and the United Kingdom.
Deinove SA is a France-based company active in the renewable fuels sector. It specializes in the development and commercial exploitation of processes for production of biofuels and other compounds of industrial or pharmaceutical value.
Theradiag is a France-based company which develops and markets biological diagnostic tools. The company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.
AS Group
Funding Round in 2005
AS Group is a Parisian company and a spin-off of Deloitte, was a corporate performance software vendor.
EquiTime provides organizations with Workforce Management Solutions which allow them to build, follow, count and analyse employee schedules while respecting the specificities of each profession. EquiTime renews the traditional concepts of time and activity management by adding the forecasting dimension to that of the actual work already done, which represents a source of increased productivity, and an improvement in the relations between company employees and customers.
Theradiag is a France-based company which develops and markets biological diagnostic tools. The company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.